Mapping inflammation onto mood: inflammatory mediators of anhedonia
Swardfager, Walter, Rosenblat, Joshua D., Benlamri, Meriem, McIntyre, Roger S.·2016·Neuroscience & Biobehavioral Reviews
Cites (227)
Items 201–227 of 227
- Obesity/hyperleptinemic phenotype adversely affects hippocampal plasticity: Effects of dietary restrictionClaudia A. Grillo, Gerardo G. Piroli, Ashlie N. Evans, Victoria Alice Macht, Steven P. Wilson, Karen A. Scott, Randall R. Sakai, David D. Mott, Lawrence Patrick Reagan · 2010 · Physiology & Behavior
- Sequential improvement of anxiety, depression and anhedonia with sertraline treatment in patients with major depressionPatrice Boyer, Jean‐Pol Tassin, B. Falissart, Sylvie Troy · 2000 · Journal of Clinical Pharmacy and Therapeutics
- Analysis of Plasma Biopterin Levels in Psychiatric Disorders Suggests a Common BH4 Deficit in Schizophrenia and Schizoaffective DisorderMary Ann Richardson, Laura L. Read, Margaret A. Reilly, James D. Clelland, Catherine L. Taylor Clelland · 2006 · Neurochemical Research
- Aging leads to prolonged duration of inflammation-induced depression-like behavior caused by Bacillus Calmette-GuérinKelley, Keith W., O’Connor, Jason C., Lawson, Marcus A., Dantzer, Robert, Rodriguez-Zas, Sandra L., McCusker, Robert H. · 2013 · Brain, Behavior, and Immunity
- Role of long-chain omega-3 fatty acids in psychiatric practiceRobert K. McNamara, Jeffrey Robert Strawn · 2013 · PharmaNutrition
- Omega-3 polyunsaturated fatty acids for major depressive disorderKuan‐Pin Su, Sheng‐Min Wang, Chi‐Un Pae · 2013 · Expert Opinion on Investigational Drugs
- Poststroke Neuropsychiatric Symptoms: Relationships with IL-17 and Oxidative StressWalter Swardfager, Nathan Herrmann, Ana C. Andreazza, Richard H. Swartz, Maisha M. Khan, Sandra E. Black, Krista L. Lanctôt · 2014 · BioMed Research International
- Evidence for a Tetrahydrobiopterin Deficit in SchizophreniaM.A. Richardson, Laura L. Read, Catherine L. Taylor Clelland, Margaret A. Reilly, Helen M. Chao, Robert W. Guynn, Raymond F. Suckow, James D. Clelland · 2005 · Neuropsychobiology
- Reduced positive affect (anhedonia) is independently associated with 7-year mortality in patients treated with percutaneous coronary intervention: results from the RESEARCH registryNikki L. Damen, Aline J. M. Pelle, Eric H. Boersma, Patrick W.J.C. Serruys, Ron T. van Domburg, Susanne S. Pedersen · 2012 · European Journal of Preventive Cardiology
- Anhedonia in the age of RDoCJeffrey S. Bedwell, Diane Carol Gooding, Chi Chuen Chan, Benjamin J. Trachik · 2014 · Schizophrenia Research
- Dietary restriction reverses obesity-induced anhedoniaClaudia A. Grillo, Petra Mulder, Victoria Alice Macht, Kris Ford Kaigler, Steven P. Wilson, Marlene A. Wilson, Lawrence Patrick Reagan · 2014 · Physiology & Behavior
- Reward Responsiveness Varies by Smoking Status in Women with a History of Major Depressive DisorderAmy C. Janes, Paola Pedrelli, Alexis Estelle Whitton, Pia Pechtel, Samuel Douglas, Max A Martinson, Ilana Huz, Maurizio Fava M. D, Diego A. Pizzagalli, Anne Eden Evins · 2015 · Neuropsychopharmacology
- Kynurenine and depressive symptoms in a poststroke populationKrista L. Lanctôt, Kira Bensimon, Nathan Herrmann, Walter Swardfager, Sandra E. Black, Fuqiang Gao, Abraham Snaiderman, Hao Yi · 2014 · Neuropsychiatric Disease and Treatment
- Anhedonia is associated with poor health status and more somatic and cognitive symptoms in patients with coronary artery diseaseAline J. M. Pelle, Susanne S. Pedersen, Ruud A.M. Erdman, Marten Kazemier, Marquita Spiering, Ron T. van Domburg, Johan Denollet · 2010 · Quality of Life Research
- Maintenance therapy of celecoxib for major depression with mimicking neuropsychological dysfunctionChun‐Yen Chen, Nian‐Sheng Tzeng, Yi-Chyan Chen · 2010 · General Hospital Psychiatry
- Is there a role for curcumin in the treatment of bipolar disorder?Elisa Macedo Brietzke, Rodrigo Barbachan Mansur, André Zugman, Andre Ferrer Carvalho, Danielle S. Macêdo, Danielle S. Cha, Vanessa Costhek Abílio, Roger S. McIntyre · 2013 · Medical Hypotheses
- Post-Stroke Depression: Main Phenomenological Clusters and their Relationships with Clinical MeasuresDavide Quaranta, Camillo Marra, Guido Gainotti · 2012 · Behavioural Neurology
- The role of IL-2 and soluble IL-2R in depression and antidepressant response.Triin Eller, Veiko Vasar, Jakov Shlik, Eduard Maron · 2009 · PubMed
- Plasma soluble interleukin-2-receptor in depression: relationships to plasma neopterin and serum IL-2 concentrations and HPA-axis activityMichael H. J. Maes, E. Bosmans, Simon Scharpé, Peter D'Hondt, Roger Desnyder · 1995 · European Psychiatry
- No evidence for physical anhedonia as a candidate symptom or an endophenotype in bipolar affective disorderBruno Étain, Isabelle Roy, Chantal Henry, Angela Rousseva, Franck Schürhoff, Marion Leboyer, Frank Bellivier · 2007 · Bipolar Disorders
- Post-stroke depression: Main phenomenological clusters and their relationships with clinical measures.Davide Quaranta, Camillo Marra, Guido Gainotti · 2012 · PubMed
- Reply to: Serum Zinc and the Risk of Depression in Men: Observations from a 20-Year Follow-up StudyWalter Swardfager, Nathan Herrmann, Graham Mazereeuw, Krista L. Lanctôt · 2014 · Biological Psychiatry
- Antinuclear Factor, a Dysimmunological Feature in Mental Depression. A Preliminary CommunicationR Deberdt, J. van Hooren, Willem K. Amery · 2010 · Psychotherapy and Psychosomatics
- P3‐396: Anhedonia is associated with the risk of Alzheimer's disease in elders with mild cognitive impairment: Results from the Korean Longitudinal Study on Health and Aging (KLOSHA)Yoonseop So, Ki Woong Kim, Joon Hyuk Park · 2012 · Alzheimer s & Dementia
- An examination of anhedonia separate from depression in Alzheimer's disease: a preliminary study.Laura E. Natta, Rebecca J. Melrose, Dylan G. Harwood · 2013 · American Journal of Geriatric Psychiatry
- Neuroinflammation Mediates Synergy between Cerebral Ischemia and Amyloid-β to Cause Synaptic DepressionWalter Swardfager, Madelaine Lynch, Sonam Dubey, Paul Michael Nagy · 2014 · Journal of Neuroscience
- Comparison of pramipexole, fluoxetine, and placebo in patients with major depression2000